Related Experiment Video
Updated: Aug 5, 2026
18:01
Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 19, 2008
Aliphatic N-methylpropargylamines as potential neurorescue agents
1Neuropsychiatry Research Unit, Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. YUP@SASK.USASK.CA
Restorative Neurology and Neuroscience
|April 3, 2003
Summary
New propargylamines, selective monoamine oxidase B inhibitors, show promise for treating neurodegenerative diseases like Parkinson's and Alzheimer's by protecting neurons from damage.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- R-deprenyl, a monoamine oxidase B inhibitor, shows potential in delaying neurodegenerative diseases.
- Aliphatic N-methylpropargylamines are potent, irreversible, and selective MAO-B inhibitors.
- These compounds lack amphetamine-like effects and do not impact neurotransmitter uptake.
Purpose of the Study:
- To investigate the neuroprotective effects of aliphatic N-methylpropargylamines.
- To evaluate their efficacy in various models of neuronal damage.
- To explore their potential therapeutic applications in neurodegenerative disorders.
Main Methods:
- In vitro and in vivo MAO-B inhibition assays.
- Assessment of neuroprotection against MPTP, MK-801, and DSP-4 toxicity in mice.
- Evaluation of neuronal rescue in rodent models of kainate-induced damage and hypoxia-hypoglycemia.
- Analysis of heat shock protein (HSP70) and c-Fos expression.
Main Results:
- Aliphatic N-methylpropargylamines demonstrated potent and selective MAO-B inhibition.
- These compounds protected dopamine neurons from MPTP toxicity and prevented apoptosis.
- Neurorescue of hippocampal neurons was observed in kainate-induced and hypoxia-hypoglycemia models.
- Inhibition of HSP70 and delayed c-Fos expression was noted.
Conclusions:
- Aliphatic N-methylpropargylamines exhibit significant neuroprotective properties.
- These compounds may offer a novel therapeutic strategy for neurodegenerative diseases.
- Further research is needed to elucidate the precise mechanism and site of action for their neurorescue effects.
More Related Videos
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 27, 2016
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Related Concept Videos
01:26Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
01:28Preparation of 1° Amines: Gabriel Synthesis
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...